Tumor Ablation Devices Market Revenue Opportunies By Key Vendors Intuitive Surgical, Inc., Johnson & Johnson, Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, SonaCare Medical, LLC

Tumor ablation is a minimally invasive procedure to remove the tumor cells or tissue from the body. Tumor ablation devices are consists of a catheter, which is introduced into the tumor under imaging guidance. Advancements in cryosurgical technology and intraoperative monitoring devices have gained the adoption of tumor ablation devices by the healthcare professionals. As this technology have led to the implementation of high accuracy and precision in treating chronic diseases such as a liver tumor. The use of Microwave Ablation magnetic image-guiding systems has provided an effective adjunct in laparoscopic ablation and helps in providing better support to surgeons and increases clinical patient outcome.

The global tumor ablation devices market is valued at US$ 464.18 million in 2017 and is expected to witness a CAGR of 10.2% over the forecast period 2017 – 2025.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1270

With the robust development of imaging devices and modalities during past two decades, image guided techniques like tumor ablation has become a powerful tool for definitive treatment of certain benign and malignant tumors of the lungs, liver, kidneys, bone, and soft tissues and for pain palliation. Tumor ablation is one of the minimally invasive procedure used to destroy cancer cells in the chest, lung and liver and other areas of patients’ body. The change in lifestyle and unhealthy eating habits, along with increasing consumption of tobacco and alcohol is the leading cause for growth in number of cancer cases. As per stats released by National Cancer Institute (NCI), around 1,685,210 new cases of cancer were diagnosed in the U.S. in 2016.

Market Dynamics:
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators, etc. Moreover, key players are also indulged in offering various lucrative features to the potential buyers of the ablation devices such as hospitals and clinics that would in turn help them to grow their sales and establish a global market presence. For instance, Medtronic launched OsteoCool RF Ablation System to treat spine metastases, in January 2016. The system destroys cancer cells by using high frequency energy, and also provides procedural flexibility and tailored treatment for spine metastases. However, cost of the tumor treatment is relatively expensive which may restraint the growth of the market.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1270

Key features of the study:
• This report provides in-depth analysis of tumor ablation devices and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global tumor ablation devices market based on the following parameters – company overview, financial performance, geographical presence, key developments and strategies, and future plans
• Key companies covered as a part of this study include Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Inc., Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, SonaCare Medical, LLC., Galil Medical Inc., EDAP TMS S.A., Abbott Laboratories, NuVasive, Inc, and Alpinion Medical Systems Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, product improvement, market expansion, and marketing tactics
• The global tumor ablation devices market report caters to various stakeholders in this industry including investors, researchers, tumor ablation devices manufacturers, new entrants, and financial analysts.
• Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the tumor ablation devices market.

Detailed Segmentation:

• Company Profiles
• Boston Scientific Corporation*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
• Medtronic Plc
• Intuitive Surgical, Inc
• Johnson & Johnson, Inc
• Smith & Nephew Plc
• Angiodynamics
• HealthTronics, Inc
• SonaCare Medical, LLC
• Galil Medical Inc.
• EDAP TMS S.A
• Abbott Laboratories
• NuVasive, Inc
• Alpinion Medical Systems Co., Ltd.
• Global Tumor Ablation Devices Market, By Technology:
• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• High-Intensity Focused Ultrasound
• Laser Interstitial Thermal Ablation
• Others
• By Application:
• Breast Cancer
• Liver Cancer
• Prostate Cancer
• Lung Cancer
• Kidney Cancer
• Others

“*” marked represents similar segmentation in other categories in the respective section.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.